78
Views
6
CrossRef citations to date
0
Altmetric
Review

Current therapeutic strategies for invasive and metastatic bladder cancer

, &
Pages 97-113 | Published online: 11 Jul 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mei Sun, Jianna Zhang, Chenfei Zheng, Yi Liu, Fan Lin, Feifei Xu & Chaosheng Chen. (2015) Analysis of potential risk factors for cancer incidence in patients with aristolochic acid nephropathy from Wenzhou, China. Renal Failure 37:2, pages 209-213.
Read now

Articles from other publishers (5)

Chenglin Han, Zilong Wang, Shuxiao Chen, Lin Li, Yingkun Xu, Weiting Kang, Chunxiao Wei, Hongbin Ma, Muwen Wang & Xunbo Jin. (2021) Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF-κB Axis. Oxidative Medicine and Cellular Longevity 2021, pages 1-21.
Crossref
Nakho Chang, Hye Won Lee, Joung Eun Lim, Da Eun Jeong, Hye Jin Song, Sudong Kim, Do-Hyun Nam, Hyun Hwan Sung, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Hyun Moo Lee, Han-Yong Choi & Hwang Gyun Jeon. (2016) Establishment and antitumor effects of dasatinib and PKI-587 in BD-138T, a patient-derived muscle invasive bladder cancer preclinical platform with concomitant EGFR amplification and PTEN deletion. Oncotarget 7:32, pages 51626-51639.
Crossref
Jana Katolická. (2016) Current position of chemotherapy in treating bladder cancer. Urologie pro praxi 17:2, pages 64-68.
Crossref
Yongquan Wang, Tianying Wang, Yelu Han, Heng Wu, Wenran Zhao, Dandan Tong, Lanlan Wei, Zhaohua Zhong, Ruihua An & Yan Wang. (2015) Reduced ING4 Expression Is Associated with the Malignancy of Human Bladder. Urologia Internationalis 94:4, pages 464-471.
Crossref
Hua Gao, Yafang Guo, Ning Deng, Pingxia Fei, Xiaofeng Qiu, Ping Zheng, Jun Feng & Guidong Dai. (2014) Suppressive Effect of Matrine on Tumor Invasion in N-Butyl-N-(4-Hydroxybutyl)Nitrosamine-Induced Urinary Bladder Carcinogenesis. Chemotherapy 60:2, pages 119-128.
Crossref